Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in Nonresectable Adrenocortical Carcinoma
NCT00215202Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- Aug 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in adrenocortical carcinoma (ACC), sponsored by Dartmouth Health. Started Aug 2004; status: completed.
02
Drugs
03
Conditions
adrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT00215202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215202.